Pacira BioSciences, Inc. PCRX NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

45/100

0/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Pacira BioSciences, Inc. (PCRX), dont 23 achats et 26 ventes. Le total des achats d'initiés s'élève à $5.63M et le total des ventes d'initiés à $4.43M.

Les initiés notables ayant une activité récente comprennent Froimson Mark, Slonin Jonathan, Williams Kristen. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — PCRX

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-17	Froimson Mark	Director	Vente Informative	500	$21.81	$10.91K	20,136
2026-03-17	Slonin Jonathan	Chief Medical Officer	Vente Informative	3,261	$22.82	$74.42K	223,640
2026-02-11	Williams Kristen	Chief Administrative Officer	Attribution de RSU	54,546	-	-	185,849
2026-02-11	Riker Lauren	Senior Vice President, Finance	Attribution de RSU	19,273	-	-	71,586
2026-02-11	Cross Shawn	Chief Financial Officer	Attribution de RSU	49,091	-	-	105,341
2026-02-11	Lee Frank D.	Chief Executive Officer	Attribution de RSU	261,818	-	-	660,831
2026-02-11	Slonin Jonathan	Chief Medical Officer	Attribution de RSU	54,546	-	-	226,901
2026-02-11	Teehan Brendan	Chief Commercial Officer	Attribution de RSU	51,714	-	-	100,934
2026-02-02	Williams Kristen	Chief Administrative Officer	Vente Informative	13,137	$20.53	$269.7K	131,303
2026-02-02	Riker Lauren	Senior Vice President, Finance	Vente Informative	4,000	$20.81	$83.24K	52,313
2026-01-30	Williams Kristen	Chief Administrative Officer	Retenue Fiscale RSU	17,134	$20.54	$351.93K	144,440
2026-01-30	Riker Lauren	Senior Vice President, Finance	Retenue Fiscale RSU	2,751	$20.54	$56.51K	56,313
2026-01-30	Lee Frank D.	Chief Executive Officer	Retenue Fiscale RSU	41,488	$20.54	$852.16K	399,013
2026-01-30	Slonin Jonathan	Chief Medical Officer	Retenue Fiscale RSU	6,168	$20.54	$126.69K	172,355
2026-01-30	Teehan Brendan	Chief Commercial Officer	Retenue Fiscale RSU	5,182	$20.54	$106.44K	49,220
2026-01-27	Hirawat Samit	Director	Inconnu	-	-	-	-
2026-01-27	Hirawat Samit	Director	Attribution de RSU	39,291	$19.85	$779.93K	39,291
2026-01-05	Riker Lauren	Senior Vice President, Finance	Vente Informative	1,416	$24.24	$34.32K	59,064
2026-01-02	Riker Lauren	Senior Vice President, Finance	Retenue Fiscale RSU	159	$24.46	$3.89K	60,480
2026-01-02	Lee Frank D.	Chief Executive Officer	Retenue Fiscale RSU	9,272	$24.46	$226.79K	440,501
2026-01-02	Slonin Jonathan	Chief Medical Officer	Retenue Fiscale RSU	381	$24.46	$9.32K	178,523
2025-12-31	Teehan Brendan	Chief Commercial Officer	Attribution de RSU	402	$10.76	$4.33K	54,402
2025-12-10	Cross Shawn	Chief Financial Officer	Vente Informative	9,104	$25.14	$228.87K	56,250
2025-12-09	Cross Shawn	Chief Financial Officer	Vente Informative	15,896	$25.03	$397.88K	56,250
2025-11-17	Slonin Jonathan	Chief Medical Officer	Vente Informative	3,960	$24.09	$95.4K	178,367
2025-11-10	Cross Shawn	Chief Financial Officer	Vente Informative	12,060	$22.09	$266.41K	56,250
2025-10-31	Cross Shawn	Chief Financial Officer	Retenue Fiscale RSU	6,690	$21.38	$143.03K	68,310
2025-09-04	Ceesay Abraham	Director	Vente Informative	2,354	$27.19	$64.01K	9,039
2025-08-07	Bigal Marcelo	Director	Vente Informative	4,912	$23.67	$116.27K	11,393
2025-08-01	Slonin Jonathan	Chief Medical Officer	Retenue Fiscale RSU	315	$22.07	$6.95K	182,327
2025-06-11	Kronenfeld Mark A.	Director	Attribution de RSU	6,163	-	-	31,065
2025-06-11	Brege Laura	Director	Attribution de RSU	11,279	$24.34	$274.53K	11,279
2025-06-11	Kronenfeld Mark A.	Director	Attribution de RSU	11,279	$24.34	$274.53K	11,279
2025-06-11	Yang Michael J.	Director	Attribution de RSU	11,279	$24.34	$274.53K	11,279
2025-06-11	Froimson Mark	Director	Attribution de RSU	11,279	$24.34	$274.53K	11,279
2025-06-11	Ceesay Abraham	Director	Attribution de RSU	11,279	$24.34	$274.53K	11,279
2025-06-11	Christie Christopher	Director	Attribution de RSU	11,279	$24.34	$274.53K	11,279
2025-06-11	Young Alethia	Director	Attribution de RSU	11,279	$24.34	$274.53K	11,279
2025-06-11	Bigal Marcelo	Director	Attribution de RSU	11,279	$24.34	$274.53K	11,279
2025-06-04	Williams Kristen	Chief Administrative Officer	Vente Informative	14,376	$26.24	$377.23K	161,574
2025-06-04	Riker Lauren	Senior Vice President, Finance	Vente Informative	5,578	$26.21	$146.2K	59,564
2025-06-03	Williams Kristen	Chief Administrative Officer	Retenue Fiscale RSU	6,162	$26.40	$162.68K	175,950
2025-06-03	Riker Lauren	Senior Vice President, Finance	Retenue Fiscale RSU	3,374	$26.40	$89.07K	65,142
2025-06-03	Slonin Jonathan	Chief Medical Officer	Retenue Fiscale RSU	5,084	$26.40	$134.22K	181,960
2025-02-04	Teehan Brendan	Chief Commercial Officer	Attribution de RSU	99,500	$26.59	$2.65M	99,500
2025-02-01	Williams Kristen	Chief Administrative Officer	Attribution de RSU	79,200	-	-	182,112
2025-02-01	Riker Lauren	Senior Vice President, Finance	Attribution de RSU	30,600	-	-	68,516
2025-02-01	Lee Frank D.	Chief Executive Officer	Attribution de RSU	350,000	-	-	448,409
2025-02-01	Slonin Jonathan	Chief Medical Officer	Attribution de RSU	93,600	-	-	187,044
2025-02-01	Teehan Brendan	Chief Commercial Officer	Attribution de RSU	54,000	-	-	54,000

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration